With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|An Oncolytic Herpes Simplex Virus Restricted in Entry to Neuroblastoma Cells||Northwestern University Medical School / Richard Longnecker, PhD||Innovation Grants||2013||Illinois|
|DICER1, MicroRNAs and Pediatric Cancer: An Emerging Story||Research Institute of the McGill University Health Centre / William Foulkes, MD, PhD||Innovation Grants||2013||Quebec|
|Accelerating Access to Cellular Therapies for the Treatment of Childhood Malignancies||Seattle Children's Hospital and Regional Medical Center / Julie Park, MD||Phase I/II Infrastructure Grants||2013||Washington|
|Genetic Profiling and Experimental Modeling of High-risk Acute Lymphoblastic Leukemia||St. Jude Children's Research Hospital / Kathryn Roberts, PhD||Young Investigator Grants||2013||Tennessee|
|Novel Targeted Therapies for Rhabdomyosarcoma||St. Jude Children's Research Hospital / Michael Dyer, PhD||Innovation Grants||2013||Tennessee|
|Inflammatory Signaling in the Tumor Microenvironment||St. Jude Children's Research Hospital / Peter J. Murray, PhD||Springboard Grants||2013||Tennessee|
|Modeling Genetic Modifiers of Down Syndrome Leukemogenesis||Children's Hospital of Philadelphia / Stella T. Chou, MD||Springboard Grants||2013||Pennsylvania|
|Clinical Epidemiology Studies in Children's Oncology Group Clinical Trials||Children's Hospital of Philadelphia / Richard Aplenc, MD, PhD, MSCE||Epidemiology Grants||2013||Pennsylvania|
|Epigenetic Characterization of the Neuroblastoma Driver Genes ARID1A and ARID1B||Children's Hospital of Philadelphia / Michael Hogarty, MD||Innovation Grants||2013||Pennsylvania|
|Preclinical Development of Targeted Therapy for Neuroblastoma with ALK and CDK4/6 Dual Pathway Inhibition||Children's Hospital of Philadelphia / Yael Mossé, MD||Reach Grants||2013||Pennsylvania|